E1	And:T1 Arg:T30 Arg2:E4
E2	Procedure:T2 Name:T31
E3	Modifier:T3 Modifies:T32
E4	Condition:T4 Name:T32
E5	Procedure:T5 Name:T33
E6	Modifier:T6 Modifies:T33
E7	And:T7 Arg:E6 Arg2:E30
E9	Eq-Comparison:T9 Temporal-Period:T34
E11	Procedure:T11 Name:T35 Temporality:E9
E12	Eq-Comparison:T12 Temporal-Period:T36
E13	Procedure:T13 Name:T60 Temporality:E12
E14	Procedure:T14 Name:T37
E15	Procedure:T15 Name:T38
E16	Condition:T16 Name:T39
E17	Allergy:T17 Name:E18 Name2:E19 Name3:E22
E18	Drug:T18 Name:T41
E19	Drug:T19 Name:T42
E20	Or:T20 Arg:E19 Arg2:E22
E22	Drug:T22 Name:T45
E23	Condition:T23 Name:T47 Severity:T46
E24	Observation:T24 Name:T48 Temporality:E25 Eq-Comparison:E26
E25	Eq-Comparison:T25 Operator:T49 Value:T50 Temporal-Unit:T51
E26	Eq-Comparison:T26 Operator:T52 Value:T53
E27	Condition:T27 Name:T54 Duration:E29
E29	Eq-Comparison:T29 Value:T55 Temporal-Unit:T56 Operator:T28
E30	Modifier:T57 Modifies:T33
E8	Coreference:T8 Refers-To:E4
E31	Modifier:T58 Modifies:E8
E32	Negation:T59 Negates:E31
E10	Modifier:T10 Modifies:T35
E33	And:T61 Arg:E14 Arg2:E15
E21	Modifier:T21 Modifies:T45
E28	Modifier:T43 Modifies:T54
T1	And 38 36	with
T2	Procedure 45 43	biopsy
T3	Modifier 92 90	metastatic cervical nodal squamous cell
T4	Condition 102 100	carcinoma
T5	Procedure 110 108	CT
T6	Modifier 122 120	neck
T7	And 127 125	with
T9	Eq-Comparison 224 222	Planned
T11	Procedure 272 266	PET CT examination
T12	Eq-Comparison 285 279	Planned
T13	Procedure 307 301	care exam
T14	Procedure 324 318	anesthesia
T15	Procedure 359 353	oropharyngeal surgical biopsy
T16	Condition 395 387	Pregnant
T17	Allergy 420 412	allergy
T18	Drug 427 419	FDG
T19	Drug 442 433	fluciclovine
T20	Or 447 437	or
T22	Drug 478 466	contrast agents
T23	Condition 508 496	renal dysfunction
T24	Observation 535 522	glomerular filtrate rate
T25	Eq-Comparison 553 538	within 30 days
T26	Eq-Comparison 569 552	less than 30
T27	Condition 612 593	Inability to tolerate lying supine
T29	Eq-Comparison 654 633	up to 1 hour
T30	Life-Stage-And-Gender 33 31	Adults
T31	Procedure-Name 45 43	biopsy
T32	Condition-Name 102 100	carcinoma
T33	Procedure-Name 110 108	CT
T34	Eq-Temporal-Period 224 222	Planned
T35	Procedure-Name 272 266	PET CT examination
T36	Eq-Temporal-Period 285 279	Planned
T37	Procedure-Name 324 318	anesthesia
T38	Procedure-Name 359 353	oropharyngeal surgical biopsy
T39	Condition-Name 395 387	Pregnant
T40	Life-Stage-And-Gender 401 393	women
T41	Drug-Name 427 419	FDG
T42	Drug-Name 442 433	fluciclovine
T45	Drug-Name 478 466	contrast agents
T46	Severity 490 478	Severe
T47	Condition-Name 508 496	renal dysfunction
T48	Observation-Name 535 522	glomerular filtrate rate
T49	Eq-Operator 544 530	within
T50	Eq-Value 548 533	30
T51	Eq-Temporal-Unit 553 538	days
T52	Eq-Operator 565 549	less than
T53	Eq-Value 569 552	30
T54	Condition-Name 612 593	Inability to tolerate lying supine
T55	Eq-Value 649 628	1
T56	Eq-Temporal-Unit 654 633	hour
T57	Modifier 136 134	contrast
T8	Coreference 211 209	disease
T58	Modifier 200 198	primary oropharyngeal site
T59	Negation 150 148	not
T10	Modifier 253 247	18F-FDG
T60	Procedure-Name 307 301	care exam
T61	And 329 323	with
T21	Modifier 462 450	iodine-based
T28	Eq-Operator 646 626	up to
T43	Modifier 636 616	relatively motionless
A1	Life-Stage-And-Gender-Type T30 adult
A2	Eq-Temporal-Period-Value T34 future
A3	Eq-Temporal-Period-Value T36 future
A4	Life-Stage-And-Gender-Type T40 female
A6	Severity-Value T46 severe
A7	Observation-Type-Value T48 lab
A8	Eq-Operator-Value T49 LTEQ
A9	Eq-Temporal-Unit-Value T51 day
A10	Eq-Operator-Value T52 LT
A11	Eq-Temporal-Unit-Value T56 hour
A5	Eq-Operator-Value T28 LTEQ
R1	Found-By Arg1:E4 Arg2:E2
R2	Treatment-For Arg1:E5 Arg2:E8
R3	Using Arg1:E13 Arg2:E14
R4	Using Arg1:E13 Arg2:E15
R5	If-Then Arg1:E16 Arg2:T40
R6	Equivalent-To Arg1:E24 Arg2:E23